Campoy Carlos
Insider CIK 1761518 · ALDR Chief Financial Officer · CTMX Chief Financial Officer · ZYME Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZYME Zymeworks Inc. | A Award deriv | 2026-01-12 | 2026-01-12 | 7,700 | — | $0 | 7,700 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2026-01-12 | 2026-01-12 | 11,500 | — | $0 | 11,500 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2024-12-10 | 2024-12-12 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2023-12-07 | 2023-12-08 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2023-06-30 | 2023-06-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2023-03-16 | 2023-03-20 | 1,748 | $1.98 | $3.5K | 38,224 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2022-07-20 | 2022-07-21 | 3,949 | $1.42 | $5.6K | 39,972 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2022-07-19 | 2022-07-21 | 15,000 | — | $0 | 43,921 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2022-02-02 | 2022-02-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2022-02-02 | 2022-02-04 | 22,500 | — | $0 | 28,921 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2021-10-24 | 2021-10-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2021-10-24 | 2021-10-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2021-05-31 | 2021-06-08 | 3,320 | $6.09 | $20.2K | 6,421 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2021-02-26 | 2021-03-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2020-11-30 | 2020-12-07 | 3,101 | $6.39 | $19.8K | 3,101 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2020-03-23 | 2020-03-25 | 350,000 | — | $0 | 350,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 270,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2018-12-12 | 2018-12-14 | 270,000 | — | $0 | 270,000 | SEC↗ |